Trial Outcomes & Findings for Hyperbaric Oxygen and Outcome After Below Knee Amputations (NCT NCT04717557)

NCT ID: NCT04717557

Last Updated: 2025-08-11

Results Overview

Recruitment status

TERMINATED

Study phase

PHASE1/PHASE2

Target enrollment

4 participants

Primary outcome timeframe

During inpatient stay immediately after amputation, up to 13 days

Results posted on

2025-08-11

Participant Flow

Recruitment was in hospital.

Participant milestones

Participant milestones
Measure
Hyperbaric Oxygen Plus Regular Care
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
Usual care for patients with amputation.
Overall Study
STARTED
3
1
Overall Study
COMPLETED
0
1
Overall Study
NOT COMPLETED
3
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Hyperbaric Oxygen Plus Regular Care
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
Usual care for patients with amputation.
Overall Study
Withdrawal by Subject
2
0
Overall Study
Death
1
0

Baseline Characteristics

Hyperbaric Oxygen and Outcome After Below Knee Amputations

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Hyperbaric Oxygen Plus Regular Care
n=3 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation.
Total
n=4 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
n=99 Participants
0 Participants
n=107 Participants
2 Participants
n=206 Participants
Age, Categorical
>=65 years
1 Participants
n=99 Participants
1 Participants
n=107 Participants
2 Participants
n=206 Participants
Age, Continuous
52 years
n=99 Participants
74 years
n=107 Participants
57.5 years
n=206 Participants
Sex: Female, Male
Female
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Sex: Female, Male
Male
3 Participants
n=99 Participants
1 Participants
n=107 Participants
4 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=99 Participants
0 Participants
n=107 Participants
1 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants
n=99 Participants
1 Participants
n=107 Participants
3 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=99 Participants
1 Participants
n=107 Participants
2 Participants
n=206 Participants
Race (NIH/OMB)
White
1 Participants
n=99 Participants
0 Participants
n=107 Participants
1 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=99 Participants
0 Participants
n=107 Participants
1 Participants
n=206 Participants
Region of Enrollment
United States
3 participants
n=99 Participants
1 participants
n=107 Participants
4 participants
n=206 Participants

PRIMARY outcome

Timeframe: During inpatient stay immediately after amputation, up to 13 days

Outcome measures

Outcome measures
Measure
Hyperbaric Oxygen Plus Regular Care
n=3 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation (dressing changes and treatment of infection) will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation, including dressing changes and treatment of infection.
Number of Participants With Mortality During the Inpatient Period
1 Participants
0 Participants

PRIMARY outcome

Timeframe: Up to 90 days after amputation

Population: One participant in the Hyperbaric Oxygen Plus Regular Care arm died following amputation.

Unplanned return to the OR (operating room) for a surgical procedure

Outcome measures

Outcome measures
Measure
Hyperbaric Oxygen Plus Regular Care
n=2 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation (dressing changes and treatment of infection) will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation, including dressing changes and treatment of infection.
Number of Participants With Re-operation
0 Participants
0 Participants

PRIMARY outcome

Timeframe: Up to 90 days after amputation

Population: One participant in the Hyperbaric Oxygen Plus Regular Care arm died following amputation.

Any wound site infection that was culture positive or required antibiotic treatment

Outcome measures

Outcome measures
Measure
Hyperbaric Oxygen Plus Regular Care
n=2 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation (dressing changes and treatment of infection) will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation, including dressing changes and treatment of infection.
Number of Participants With Wound Infection
0 Participants
0 Participants

SECONDARY outcome

Timeframe: up to approximately 30 days

Hospital length of stay immediately after amputation

Outcome measures

Outcome measures
Measure
Hyperbaric Oxygen Plus Regular Care
n=3 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation (dressing changes and treatment of infection) will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation, including dressing changes and treatment of infection.
Hospital Length of Stay
5.3 days
Interval 4.0 to 7.0
13 days
Interval 13.0 to 13.0

SECONDARY outcome

Timeframe: Up to 90 days after amputation

Death within 90 days after amputation

Outcome measures

Outcome measures
Measure
Hyperbaric Oxygen Plus Regular Care
n=3 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation (dressing changes and treatment of infection) will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation, including dressing changes and treatment of infection.
Number of Participants With 90-day Mortality
1 Participants
0 Participants

SECONDARY outcome

Timeframe: 4 weeks after amputation

Population: One participant in the Hyperbaric Oxygen Plus Regular Care arm died following amputation.

Complete wound healing at 4 weeks after amputation

Outcome measures

Outcome measures
Measure
Hyperbaric Oxygen Plus Regular Care
n=2 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation (dressing changes and treatment of infection) will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation, including dressing changes and treatment of infection.
Number of Participants With Complete Healing of Amputation Wound Healing at 4 Weeks Following Surgery
0 Participants
0 Participants

SECONDARY outcome

Timeframe: 8 weeks after amputation

Population: One participant in the Hyperbaric Oxygen Plus Regular Care arm died following amputation.

Complete wound healing at 8 weeks after amputation

Outcome measures

Outcome measures
Measure
Hyperbaric Oxygen Plus Regular Care
n=2 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation (dressing changes and treatment of infection) will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation, including dressing changes and treatment of infection.
Number of Participants With Complete Healing of Amputation Wound Healing at 8 Weeks Following Surgery
1 Participants
0 Participants

SECONDARY outcome

Timeframe: 6 months after amputation

Population: One participant in the Hyperbaric Oxygen Plus Regular Care arm died following amputation.

Ability to ambulate with a prosthesis at 6 months post amputation

Outcome measures

Outcome measures
Measure
Hyperbaric Oxygen Plus Regular Care
n=2 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation (dressing changes and treatment of infection) will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation, including dressing changes and treatment of infection.
Number of Participants Able to Ambulate With Prosthesis
2 Participants
0 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Up to 90 days after amputation

Population: One participant in the Hyperbaric Oxygen Plus Regular Care arm died following amputation.

Any readmission to hospital after initial discharge

Outcome measures

Outcome measures
Measure
Hyperbaric Oxygen Plus Regular Care
n=2 Participants
Hyperbaric oxygen (2 hours at 2 atmospheres absolute) to be administered 1-2 times daily for up to 10 treatments after amputation. Usual care for patients with amputation (dressing changes and treatment of infection) will be administered in parallel. Hyperbaric Oxygen: Hyperbaric oxygen (HBO2) 1-2 times daily for up to 10 times after amputation
Regular Care
n=1 Participants
Usual care for patients with amputation, including dressing changes and treatment of infection.
Number of Participants With Hospital Readmission
0 Participants
1 Participants

Adverse Events

Hyperbaric Oxygen Plus Regular Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Regular Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Richard Moon

Duke University

Phone: 919-684-8762

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place